Octaplas Approval History
- FDA approved: Yes (First approved January 17th, 2013)
- Brand name: Octaplas
- Generic name: pooled plasma (human)
- Dosage form: Solution for Intravenous Infusion
- Company: Octapharma
- Treatment for: Bleeding Disorder
Octaplas is a solvent/detergent (S/D) treated, pooled human plasma indicated for the replacement of multiple coagulation factors in patients with acquired deficiencies and plasma exchange in patients with thrombotic thrombocytopenic purpura.
Development History and FDA Approval Process for Octaplas
|Jan 17, 2013||FDA Approves Octaplas to Treat Patients with Blood Clotting Disorders|
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.